Webinars & Videos

WuXi STA New Modality CRDMO Business Introduction

Protein therapeutics have played an important role in medicine since the advent of insulin therapy to treat diabetes in the 1920s. More recently, peptides have emerged as valuable therapeutics with attractive drug properties.

A 12-minute webinar presented by Pete Nguyen, Ph.D., Director Business Development Oligo/Peptide, WuXi STA

Watch this video presented by Jinling Chen, Ph.D., Senior Vice President DP Business and Yu Lu, Senior Vice President Business Operations

Watch this webinar presented by Graham Ogg, Professor, MRC Weatherall Institute of Molecular Medicine, University of Oxford and Hui Liao Associate Director, Chemistry Service Unit (CSU), WuXi AppTec

Attend our webinar co-presented by Yen-Huei Lin, Ph.D. Exec. Director, Biopharmaceutical Development and Manufacturing at Neuraly and William Fang, Head of Oligo/Peptide Business at WuXi STA about how an integrated CMC partnership was critical in accelerating a novel peptide to phase 1 clinical trial.